Neurogen cell-based brain implant repairs and restore damage in the cortex due to neurological diseases through minimally-invasive system.
Neurogen is a biotech start-up that aims to address severe socioeconomic, and environmental impacts caused by brain lesions and subsequent lifetime disabilities across the globe.
Neurogen envisions a future with hope for patients of neurodegenerative disorders (Alzheimer's and Parkinson's diseases) and expanding to other cortical lesions caused by stroke and neurodevelopmental disorders (Autism).
Our aim is to build a future where brain cortical lesions are no longer a concern and bring hope to people's lives “because everyone deserves a healthy brain”.
Company Details
- Employees
- 2
- Founded
- 2023
- Address
- Melbourne, Au
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.neurogenglobal.com
- Keywords
- Melbourne.
- HQ
- Melbourne
Neurogen Questions
Neurogen's website is http://www.neurogenglobal.com
Neurogen's LinkedIn profile is https://au.linkedin.com/company/neurogen-global
Neurogen has
2 employees.
View email and phone details for 2
employees at Neurogen.
Neurogen's industry is
Biotechnology Research
Neurogen's top competitors are
Chyral,
Tessara Therapeutics,
Immunosis,
Pacalis Therapeutics Pty Ltd,
Misti,
Turquoise Biotechnologies,
The Leaf Protein Company,
Next Level Collaboration,
Solara Health,
Proxima Bio.
Neurogen's categories are Biotechnology Research
Neurogen's founding year is 2023
